{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:16:47Z","timestamp":1781659007295,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroradiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.neurad.2024.03.001","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T07:51:02Z","timestamp":1710402662000},"page":"101190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic validity and reliability of BT-RADS in the management of recurrent high-grade glioma"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2658-6156","authenticated-orcid":false,"given":"Noha Yahia","family":"Ebaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha Nadeem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa Mohamad","family":"Assy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ibrahim","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamad","family":"Alaa Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Alsowey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabab Mohamed","family":"Abdelhay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl_4","key":"10.1016\/j.neurad.2024.03.001_bib0001","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neurad.2024.03.001_bib0002","series-title":"Tumours of the Nervous System: World Health Organization Classification of Tumours","year":"2000"},{"issue":"4","key":"10.1016\/j.neurad.2024.03.001_bib0003","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastomadefinition of primary and secondary glioblastomas","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clinical cancer research"},{"issue":"3","key":"10.1016\/j.neurad.2024.03.001_bib0004","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1148\/radiology.152.3.6463251","article-title":"Comparison of CT and MR in 400 patients with suspected disease of the brain and cervical spinal cord","volume":"152","author":"Bradley","year":"1984","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.neurad.2024.03.001_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1602\/neurorx.2.2.333","article-title":"Imaging in neurooncology","volume":"2","author":"Jacobs","year":"2005","journal-title":"NeuroRx"},{"issue":"1","key":"10.1016\/j.neurad.2024.03.001_bib0006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/02688697.2017.1368449","article-title":"Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre","volume":"32","author":"Loh","year":"2018","journal-title":"Br J Neurosurg"},{"issue":"1","key":"10.1016\/j.neurad.2024.03.001_bib0007","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11060-013-1096-4","article-title":"Steroid management in newly diagnosed glioblastoma","volume":"113","author":"Deutsch","year":"2013","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.neurad.2024.03.001_bib0008","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/1097-0142(20000801)89:3<640::AID-CNCR20>3.0.CO;2-E","article-title":"The risk of venous thromboembolism is increased throughout the course of malignant glioma: an evidence based review","volume":"89","author":"Marras","year":"2000","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.neurad.2024.03.001_bib0009","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.neurad.2024.03.001_bib0010","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/jnen\/64.6.479","article-title":"Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas","volume":"64","author":"Ohgaki","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"10.1016\/j.neurad.2024.03.001_bib0011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.neurad.2024.03.001_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2214\/AJR.09.4110","article-title":"Van den Abbeele AD. Revised RECIST guideline version 1.1: what oncologists want to know and what radiologists need to know","volume":"195","author":"Nishino","year":"2010","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.neurad.2024.03.001_bib0013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3171\/jns.1977.47.3.0329","article-title":"Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors","volume":"47","author":"Levin","year":"1977","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.neurad.2024.03.001_bib0014","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.1990.8.7.1277","article-title":"Response criteria for phase II studies of supratentorial malignant glioma","volume":"8","author":"Macdonald","year":"1990","journal-title":"J clin Oncol"},{"issue":"4","key":"10.1016\/j.neurad.2024.03.001_bib0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.mric.2016.06.003","article-title":"Response assessment in neuro-oncology criteria and clinical endpoints","volume":"24","author":"Huang","year":"2016","journal-title":"Magnetic Resonance Imaging Clin"},{"key":"10.1016\/j.neurad.2024.03.001_bib0016","series-title":"Breast Imaging Reporting and Data System (BI-RADS)","author":"D'Orsi","year":"2018"},{"issue":"5","key":"10.1016\/j.neurad.2024.03.001_bib0017","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacr.2017.01.046","article-title":"ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee","volume":"14","author":"Tessler","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"5","key":"10.1016\/j.neurad.2024.03.001_bib0018","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1148\/rg.2019190087","article-title":"BI-RADS, C-RADS, CAD-RADS, LI-RADS, Lung-RADS, NI-RADS, O-RADS, PI-RADS, TI-RADS: reporting and Data Systems","volume":"39","author":"An","year":"2019","journal-title":"Radiographics"},{"issue":"5","key":"10.1016\/j.neurad.2024.03.001_bib0019","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jacr.2018.01.022","article-title":"Management-based structured reporting of posttreatment glioma response with the brain tumor reporting and data system","volume":"15","author":"Weinberg","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"7","key":"10.1016\/j.neurad.2024.03.001_bib0020","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.acra.2018.12.023","article-title":"Institutional implementation of a structured reporting system: our experience with the brain tumor reporting and data system","volume":"26","author":"Gore","year":"2019","journal-title":"Acad Radiol"},{"key":"10.1016\/j.neurad.2024.03.001_bib0021","doi-asserted-by":"crossref","first-page":"h5527","DOI":"10.1136\/bmj.h5527","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.neurad.2024.03.001_bib0022","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11060-019-03387-6","article-title":"Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas","volume":"146","author":"Yang","year":"2020","journal-title":"J Neurooncol"},{"key":"10.1016\/j.neurad.2024.03.001_bib0023","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.wneu.2017.11.181","article-title":"Diagnostic performance of increased signal intensity within the resection cavity on fluid-attenuated inversion recovery sequences for detection of progression in patients with glioma","volume":"110","author":"Zhang","year":"2018","journal-title":"World Neurosurg"},{"issue":"3","key":"10.1016\/j.neurad.2024.03.001_bib0024","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1148\/radiol09090893","article-title":"Partially resected gliomas: diagnostic performance of fluid-attenuated inversion recovery MR imaging for detection of progression","volume":"254","author":"Winterstein","year":"2010","journal-title":"Radiology"},{"issue":"10","key":"10.1016\/j.neurad.2024.03.001_bib0025","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00330-017-4789-9","article-title":"Diagnostic accuracy of magnetic resonance imaging techniques for treatment response evaluation in patients with high-grade glioma, a systematic review and meta-analysis","volume":"27","author":"van Dijken","year":"2017","journal-title":"Eur Radiol"},{"issue":"Suppl 6","key":"10.1016\/j.neurad.2024.03.001_bib0026","doi-asserted-by":"crossref","first-page":"vi163","DOI":"10.1093\/neuonc\/noz175.682","article-title":"NIMG-10. brain tumor mri structured reporting allows calculation of interrater agreement of patients reviewed at tumor board","volume":"21","author":"Cooper","year":"2019","journal-title":"Neuro Oncol"}],"container-title":["Journal of Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986124001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0150986124001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T01:25:21Z","timestamp":1716600321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0150986124001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0150986124001111"],"URL":"https:\/\/doi.org\/10.1016\/j.neurad.2024.03.001","relation":{},"ISSN":["0150-9861"],"issn-type":[{"value":"0150-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic validity and reliability of BT-RADS in the management of recurrent high-grade glioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroradiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurad.2024.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101190"}}